These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17921867)

  • 1. Perceptual visual filling-in of toxoplasmic retinochoroiditis scotomas.
    Alvarenga DP; Couto MF; Pessoa VF
    Neuroreport; 2007 Oct; 18(16):1679-81. PubMed ID: 17921867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filling in at partially deafferented visual cortex.
    Alvarenga DP; Couto MF; Pessoa VF
    Br J Ophthalmol; 2008 Sep; 92(9):1257-60. PubMed ID: 18621793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns.
    Türkcü FM; Şahin A; Yüksel H; Çınar Y; Cingü K; Altındağ S; Deveci Ö; Özkurt Z; Çaça İ
    Int Ophthalmol; 2017 Jun; 37(3):559-563. PubMed ID: 27480335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptual filling-in at the scotoma following a monocular retinal lesion in the monkey.
    Murakami I; Komatsu H; Kinoshita M
    Vis Neurosci; 1997; 14(1):89-101. PubMed ID: 9057272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptual filling in of artificially induced scotomas in human vision.
    Ramachandran VS; Gregory RL
    Nature; 1991 Apr; 350(6320):699-702. PubMed ID: 2023631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
    Aleixo AL; Curi AL; Benchimol EI; Amendoeira MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004685. PubMed ID: 27136081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The visual field in toxoplasmic retinochoroiditis.
    Stanford MR; Tomlin EA; Comyn O; Holland K; Pavesio C
    Br J Ophthalmol; 2005 Jul; 89(7):812-4. PubMed ID: 15965156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual function and macular architecture in patients with inactive zone 2 and 3 toxoplasmic retinochoroiditis.
    Azevedo MH; Moura GL; Camilo EN; Muccioli C; Arantes TE
    Arq Bras Oftalmol; 2015; 78(5):273-7. PubMed ID: 26466223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmic retinochoroiditis: resolution without treatment of the perilesional satellite dark dots seen by indocyanine green angiography.
    Guex-Crosier Y; Auer C; Bernasconi O; Herbort CP
    Graefes Arch Clin Exp Ophthalmol; 1998 Jun; 236(6):476-8. PubMed ID: 9646094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of cells in monkey visual cortex during perceptual filling-in of an artificial scotoma.
    De Weerd P; Gattass R; Desimone R; Ungerleider LG
    Nature; 1995 Oct; 377(6551):731-4. PubMed ID: 7477262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptual filling-in from the edge of the blind spot.
    Spillmann L; Otte T; Hamburger K; Magnussen S
    Vision Res; 2006 Nov; 46(25):4252-7. PubMed ID: 17034833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxoplasmic chorioretinitis complicated by retinal detachment].
    Frau E; Gregoire-Cassoux N; Lautier-Frau M; Labetoulle M; Lehoang P; Offret H
    J Fr Ophtalmol; 1997; 20(10):749-52. PubMed ID: 9587588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The causes of tissue damage in toxoplasmic retinochoroiditis.
    Dutton GN
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 4)():404-12. PubMed ID: 3538518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optokinetic nystagmus elicited by filling-in in adults with central scotoma.
    Valmaggia C; Gottlob I
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1804-8. PubMed ID: 12036982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eccentric fixation patterns, clinical findings, and reading speed in patients with bilateral toxoplasmic macular retinochoroiditis.
    Antunes-Foschini RMS; Ho W; Messias A
    Arq Bras Oftalmol; 2018; 81(5):401-407. PubMed ID: 30208142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic nerve changes in ocular toxoplasmosis.
    Eckert GU; Melamed J; Menegaz B
    Eye (Lond); 2007 Jun; 21(6):746-51. PubMed ID: 16575416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in ocular toxoplasmosis.
    Wakefield D; Cunningham ET; Pavesio C; Garweg JG; Zierhut M
    Ocul Immunol Inflamm; 2011 Feb; 19(1):2-9. PubMed ID: 21250922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis.
    Montoya JG; Parmley S; Liesenfeld O; Jaffe GJ; Remington JS
    Ophthalmology; 1999 Aug; 106(8):1554-63. PubMed ID: 10442904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.
    Vishnevskia-Dai V; Achiron A; Buhbut O; Berar OV; Musika AA; Elyashiv SM; Hecht I
    Int Ophthalmol; 2020 Apr; 40(4):811-821. PubMed ID: 31792847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illusory stimuli can be used to identify retinal blind spots.
    Crossland MD; Dakin SC; Bex PJ
    PLoS One; 2007 Oct; 2(10):e1060. PubMed ID: 17957244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.